RT Journal Article
SR Electronic
A1 Helwick, Caroline
T1 Diabetic Peripheral Neuropathy: More Effective Treatments Needed
JF MD Conference Express
YR 2007
FD SAGE Publications
VO 7
IS 6
SP 26
OP 27
DO 10.1177/155989770700700619
UL http://mdc.sagepub.com/content/7/6/26.abstract
AB In a pooled analysis of 1,510 patients enrolled in seven randomized controlled trials, pregabalin (150–600 mg/day) provided significant improvements in pain, sleep interference due to pain, and global health. Improvements in pain were dose-related; a clinically meaningful (=30%) improvement in pain was noted by 43%–62%, though 37% of placebo patients also reported this level of improvement.